TickerFacts.

Pelthos Therapeutics Inc. (PTHS): Share Repurchases

Annual figures by period end, from SEC filings.

$0
Year ended 2025-12-31
$75.0K2024-12-31: $75.0K2025-12-31: $0$0
2024-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$0-100.0%2026-03-19, From 2025-01-01
2024-12-31$75.0Kn/a2026-03-19, From 2024-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Pelthos Therapeutics Inc. (PTHS)2025-12-31$0-100.0%
C4 Therapeutics, Inc. (CCCC)2025-12-31$193.0K-0.5%
Invivyd, Inc. (IVVD)2024-12-31$0-100.0%
Champions Oncology, Inc. (CSBR)2025-04-30$0-100.0%
Prokidney Corp. (PROK)2025-12-31$0n/a
ADMA Biologics, Inc. (ADMA)2025-12-31$31.94Mn/a
Repligen Corp (RGEN)2025-12-31$0n/a
Bio-Techne Corp (TECH)2026-06-30$41.67M-84.9%
Halozyme Therapeutics, Inc. (HALO)2025-12-31$342.37M+36.9%

Compare PTHS, CCCC, IVVD, CSBR side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗